Lisa Olivo of Nutraceuticals World recently featured Pete Maletto, Sr. Scientist & President of PTM Food Consulting in an article analyzing the status of the Antioxidant Market. Check out a quick sneak-peak below, and head over to Nutraceuticals World to read the full-story!
Mr. Maletto attributed growth to extensive research backing the inhibition of cancer, arthritis, diabetes, cardiovascular disease, osteoporosis, and potentially reversing the pathological processes underlying Alzheimer’s disease. For example, curcumin may reduce deadly beta amyloid plaques in the brain. It may also assist the liver in processing viruses such as hepatitis, and other conditions.
Additionally, he said one of curcumin’s most important mechanisms of action is “its ability to inhibit activation of the transcription factor, nuclear factor-kappa B (NF-kB), a potent inducer of chronic inflammation. NF-kB is a protein that acts as a sort of switch, turning inflammation on by activating genes involved in the production of inflammatory compounds. As NF-kB activation has been implicated in all the stages of carcinogenesis, this transcription factor is a potential target in cancer prevention and is the subject of intensive research.”